Back to Delaware

SCR184 • 2025

DESIGNATING MAY 3 – 9, 2026, AS “TARDIVE DYSKINESIA AWARENESS WEEK” IN THE STATE OF DELAWARE.

DESIGNATING MAY 3 – 9, 2026, AS “TARDIVE DYSKINESIA AWARENESS WEEK” IN THE STATE OF DELAWARE.

Healthcare
Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Last action
2026-05-13
Official status
Passed In House by Voice Vote
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

DESIGNATING MAY 3 – 9, 2026, AS “TARDIVE DYSKINESIA AWARENESS WEEK” IN THE STATE OF DELAWARE.

DESIGNATING MAY 3 – 9, 2026, AS “TARDIVE DYSKINESIA AWARENESS WEEK” IN THE STATE OF DELAWARE.

What This Bill Does

  • DESIGNATING MAY 3 – 9, 2026, AS “TARDIVE DYSKINESIA AWARENESS WEEK” IN THE STATE OF DELAWARE.
  • This Concurrent Resolution designates May 3 – 9, 2026, as “Tardive Dyskinesia Awareness Week” in the State of Delaware to raise awareness about tardive dyskinesia (TD), an involuntary movement disorder associated with certain medications, and encourages individuals experiencing symptoms to consult their healthcare provider.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-05-13 Delaware General Assembly

    Passed In House by Voice Vote

  2. 2026-05-07 Delaware General Assembly

    Introduced in Senate

  3. 2026-05-07 Delaware General Assembly

    Passed By Senate. Votes: 19 YES 2 ABSENT

Official Summary Text

DESIGNATING MAY 3 – 9, 2026, AS “TARDIVE DYSKINESIA AWARENESS WEEK” IN THE STATE OF DELAWARE.
This Concurrent Resolution designates May 3 – 9, 2026, as “Tardive Dyskinesia Awareness Week” in the State of Delaware to raise awareness about tardive dyskinesia (TD), an involuntary movement disorder associated with certain medications, and encourages individuals experiencing symptoms to consult their healthcare provider.